Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial

被引:117
作者
Farooq, Vasim [1 ]
Serruys, Patrick W. [1 ]
Bourantas, Christos [1 ]
Vranckx, Pascal [1 ]
Diletti, Roberto [1 ]
Garcia, Hector M. Garcia [1 ]
Holmes, David R. [2 ]
Kappetein, Arie-Pieter [3 ]
Mack, Michael [4 ]
Feldman, Ted [5 ]
Morice, Marie Claude [6 ]
Colombo, Antonio [7 ]
Morel, Marie-angele [8 ]
de Vries, Ton [8 ]
van Es, Gerrit Anne [8 ]
Steyerberg, Ewout W. [9 ]
Dawkins, Keith D. [10 ]
Mohr, Friedrich W. [11 ]
James, Stefan [12 ]
Stahle, Elisabeth [12 ]
机构
[1] Erasmus MC, Dept Intervent Cardiol, Thoraxctr, NL-3015 CE Rotterdam, Netherlands
[2] Mayo Clin, Rochester, MN USA
[3] Erasmus MC, Dept Cardiothorac Surg, Thoraxctr, NL-3015 CE Rotterdam, Netherlands
[4] Med City Dallas Hosp, Dallas, TX USA
[5] Northwestern Univ, Evanston Hosp, Evanston, IL 60201 USA
[6] Inst Jacques Cartier, Massy, France
[7] Ist Sci San Raffaele, I-20132 Milan, Italy
[8] Cardialysis BV, Rotterdam, Netherlands
[9] Erasmus MC, Dept Publ Hlth, NL-3015 CE Rotterdam, Netherlands
[10] Boston Sci Corp, Natick, MA USA
[11] Herzzentrum, Leipzig, Germany
[12] Univ Uppsala Hosp, Uppsala, Sweden
关键词
SYNTAX score; Death; SYNTAX trial; Multivariable correlates; Gender; EXPERT CONSENSUS DOCUMENT; FOUNDATION TASK-FORCE; ANKLE-BRACHIAL INDEX; 4-YEAR FOLLOW-UP; LEFT MAIN; 3-VESSEL DISEASE; BYPASS SURGERY; GASTROINTESTINAL RISKS; ANGIOGRAPHIC OUTCOMES; ANTIPLATELET THERAPY;
D O I
10.1093/eurheartj/ehs367
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The aim of this investigation was to determine the incidence and multivariable correlates of long-term (4-year) mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention (PCI) with TAXUS Express and Cardiac Surgery (SYNTAX) trial. Methods and results A total of 1800 patients were randomized to undergo coronary artery bypass graft (CABG) surgery (n = 897) or PCI (n = 903). Prospectively collected baseline and peri-and post-procedural data were used to determine independent correlates of 4-year all-cause death in the CABG and the PCI arms (Cox proportional hazards model). Four-year mortality rates in the CABG and the PCI arms were 9.0% [74 deaths (12 in-hospital)] and 11.8% [104 deaths (16 in-hospital)], respectively (log-rank P-value = 0.063). Censored data comprised 78 patients (8.7%) in the CABG arm, and 24 patients (2.7%) in the PCI arm (log-rank P-value < 0.001). Within the CABG arm, the strongest independent correlates of 4-year mortality were lack of discharge aspirin [hazard ratio (HR) 3.56; 95% CI: 2.04, 6.21; P < 0.001], peripheral vascular disease (PVD) (HR: 2.65; 95% CI: 1.49, 4.72; P = 0.001), chronic obstructive pulmonary disease, age, and serum creatinine. Within the PCI arm, the strongest independent correlate of 4-year mortality was lack of post-procedural anti-platelet therapy (HR: 152.16; 95% CI: 53.57, 432.22; P < 0.001), with 10 reported early (within 45 days) in-hospital deaths secondary to multifactorial causes precluding administration of anti-platelet therapy. Other independent correlates of mortality in the PCI arm included amiodarone therapy on discharge, pre-procedural poor left ventricular ejection fraction, a 'history of gastrointestinal bleeding or peptic ulcer disease', PVD (HR: 2.13; 95% CI: 1.26, 3.60; P = 0.005), age, female gender (HR: 1.60; 95% CI: 1.01, 2.56; P = 0.048), and the SYNTAX score (Per increase in 10 points: HR: 1.25; 95% CI: 1.06, 1.47; P = 0.007). Conclusion Independent correlates of 4-year mortality in the SYNTAX trial were multifactorial. Lack of discharge aspirin and lack of post-procedural anti-platelet therapy were the strongest independent correlates of mortality in the CABG and the PCI arms, respectively. Peripheral vascular disease is a common independent correlate of 4-year mortality and may be a marker of the severity of baseline coronary disease and risk of future native coronary disease (and extra-cardiac disease) progression.
引用
收藏
页码:3105 / 3113
页数:9
相关论文
共 47 条
[1]   ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents [J].
Abraham, Neena S. ;
Hlatky, Mark A. ;
Antman, Elliott M. ;
Bhatt, Deepak L. ;
Bjorkman, David J. ;
Clark, Craig B. ;
Furberg, Curt D. ;
Johnson, David A. ;
Kahi, Charles J. ;
Laine, Loren ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Scheiman, James ;
Sperling, Laurence S. ;
Tomaselli, Gordon F. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (24) :2051-2066
[2]   Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the bypass Angioplasty Revascularization Investigation (BARI) [J].
Alderman, EL ;
Kip, KE ;
Whitlow, PL ;
Bashore, T ;
Fortin, D ;
Bourassa, MG ;
Lesperance, J ;
Schwartz, L ;
Stadius, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (04) :766-774
[3]   ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents [J].
Bhatt, Deepak L. ;
Scheiman, James ;
Abraham, Neena S. ;
Antman, Elliott M. ;
Chan, Francis K. L. ;
Furberg, Curt D. ;
Johnson, David A. ;
Mahaffey, Kenneth W. ;
Quigley, Eamonn M. ;
Harrington, Robert A. ;
Bates, Eric R. ;
Bridges, Charles R. ;
Eisenberg, Mark J. ;
Ferrari, Victor A. ;
Hlatky, Mark A. ;
Kaul, Sanjay ;
Lindner, Jonathan R. ;
Moliterno, David J. ;
Mukherjee, Debabrata ;
Schofield, Richard S. ;
Rosenson, Robert S. ;
Stein, James H. ;
Weitz, Howard H. ;
Wesley, Deborah J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (18) :1502-1517
[4]   Clopidogrel with or without Omeprazole in Coronary Artery Disease. [J].
Bhatt, Deepak L. ;
Cryer, Byron L. ;
Contant, Charles F. ;
Cohen, Marc ;
Lanas, Angel ;
Schnitzer, Thomas J. ;
Shook, Thomas L. ;
Lapuerta, Pablo ;
Goldsmith, Mark A. ;
Laine, Loren ;
Scirica, Benjamin M. ;
Murphy, Sabina A. ;
Cannon, Christopher P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) :1909-1917
[5]   Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study [J].
Botman, Cornelis J. ;
Schonberger, Jacques ;
Koolen, Sjaak ;
Penn, Olaf ;
Botman, Hilde ;
Dib, Nabil ;
Eeckhout, Eric ;
Pijls, Nico .
ANNALS OF THORACIC SURGERY, 2007, 83 (06) :2093-2097
[6]  
Chesebro JH, 2003, NEW ENGL J MED, V348, P1057
[7]   A PLATELET-INHIBITOR-DRUG TRIAL IN CORONARY-ARTERY BYPASS OPERATIONS - BENEFIT OF PERIOPERATIVE DIPYRIDAMOLE AND ASPIRIN THERAPY ON EARLY POSTOPERATIVE VEIN-GRAFT PATENCY [J].
CHESEBRO, JH ;
CLEMENTS, IP ;
FUSTER, V ;
ELVEBACK, LR ;
SMITH, HC ;
BARDSLEY, WT ;
FRYE, RL ;
HOLMES, DR ;
VLIETSTRA, RE ;
PLUTH, JR ;
WALLACE, RB ;
PUGA, FJ ;
ORSZULAK, TA ;
PIEHLER, JM ;
SCHAFF, HV ;
DANIELSON, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (02) :73-78
[8]   EFFECT OF DIPYRIDAMOLE AND ASPIRIN ON LATE VEIN-GRAFT PATENCY AFTER CORONARY-BYPASS OPERATIONS [J].
CHESEBRO, JH ;
FUSTER, V ;
ELVEBACK, LR ;
CLEMENTS, IP ;
SMITH, HC ;
HOLMES, DR ;
BARDSLEY, WT ;
PLUTH, JR ;
WALLACE, RB ;
PUGA, FJ ;
ORSZULAK, TA ;
PIEHLER, JM ;
DANIELSON, GK ;
SCHAFF, HV ;
FRYE, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (04) :209-214
[9]  
Eagle Kim A, 2004, Circulation, V110, P1168, DOI 10.1161/01.CIR.0000138790.14877.7D
[10]  
Eagle Kim A, 2004, J Am Coll Cardiol, V44, pe213